Lilly invests $4.5 billion in a new research hub

This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. 

Good morning. Today, we look at the biggest biotech events to watch this quarter. And as my editor had to remind me (since I’m still in denial), we are indeed in the fourth quarter now.

Also, it’s not too late to get tickets for our annual STAT Summit that’s being held Boston later this month! Our final agenda just came out, featuring speakers such as Summit Therapeutics co-CEOs Bob Duggan and Maky Zanganeh, BMS CEO Chris Boerner, and Amgen CSO Jay Bradner.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $399/year

$30 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Log In